Angiolix

N/A

Report date: 2024/12/06 09:12:58

Base Information

Drug NameAngiolix
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionMilk Fat Globule EGF And Factor V/VIII Domain Containing modulators
TargetsMilk Fat Globule EGF And Factor V/VIII Domain Containing
Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAccess Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAccess Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A